P042 | PU.1 as master regulator of acute myeloid leukemia venetoclax resistance

作者
Alessandro Ferrando
出处
期刊:Haematologica [Ferrata Storti Foundation]
卷期号:111 (s1)
标识
DOI:10.3324/haematol.2026.s1.111
摘要

Introduction. Venetoclax-based therapies have improved outcomes in acute myeloid leukemia (AML), especially in elderly or unfit patients. However, resistance remains a major limitation. Recent studies suggest that monocytic differentiation (FAB M4/M5) is associated with reduced venetoclax sensitivity due to lower BCL-2 dependence and increased reliance on alternative anti-apoptotic proteins. This study investigates the link between monocytic differentiation and venetoclax resistance in AML.Methods: AML cell lines were used to assess the relationship between monocytic differentiation and venetoclax resistance. Differentiation was induced with PMA, followed by Resazurin-based viability assays. FACS analysis confirmed differentiation status, and RT-PCR was used to examine genes linked to venetoclax resistance. Transcriptomic re-analysis of venetoclax-resistant monocytic AML patients identified PU.1 as a transcription factor strongly upregulated in resistant cases. PU.1 nuclear translocation was evaluated by immunofluorescence, and ERK activation (a PU.1 regulator) was confirmed by western blot. In vitro results were validated via re-analysis of the BeatAML dataset.Results. A revised PCR-based MacScore (rMacScore) correlated with venetoclax resistance in AML cell lines. PMA-induced monocytic differentiation of THP-1, HL-60, and NB4 cells led to increased venetoclax resistance and decreased rMacScore, supporting a link between monocytic phenotype and resistance. Pre-treatment with sublethal venetoclax similarly reduced rMacScore, modestly increased resistance, and upregulated monocytic markers, suggesting venetoclax can promote monocytic differentiation and self-resistance.Transcriptomic re-analysis of venetoclax-resistant monocytic AML patients identified PU.1 as a top upregulated transcription factor. Both PMA-induced differentiation and venetoclax treatment activated PU.1 via ERK phosphorylation, leading to nuclear translocation. MEK inhibition with trametinib blocked PU.1 activation, confirming the role of ERK signaling. BeatAML data validated these findings, with rMacScore correlating with venetoclax resistance, FAB M4/M5 subtypes, and PU.1 expression.Conclusions. Our study confirms the MacScore as a surrogate marker of venetoclax resistance and supports its application in RT-PCR–based monitoring. We identify monocytic differentiation as a key driver of resistance and PU.1 as a central regulator. Venetoclax itself promotes mild monocytic differentiation and PU.1 activation, contributing to self-resistance. ERK inhibition with trametinib prevents PU.1 activation, offering a potential therapeutic strategy. BeatAML data corroborated our in vitro findings.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
坚定灭绝完成签到,获得积分10
刚刚
cy发布了新的文献求助30
刚刚
田様的应助被南楠采纳,获得10
1秒前
1秒前
LJW完成签到,获得积分10
1秒前
2秒前
科研通AI6.2的应助被quantu采纳,获得10
3秒前
zxy发布了新的文献求助10
4秒前
万能图书馆的应助被苹果思天采纳,获得10
4秒前
xmyang完成签到,获得积分10
4秒前
5秒前
天天向上的应助被子夜歌采纳,获得10
5秒前
5秒前
田様的应助被Vater采纳,获得10
5秒前
言默发布了新的文献求助10
6秒前
Anthony完成签到,获得积分10
6秒前
HOXXXiii完成签到,获得积分10
7秒前
8秒前
曾维嘉完成签到,获得积分10
8秒前
8秒前
9秒前
Howard完成签到,获得积分10
9秒前
十二月完成签到,获得积分10
11秒前
坚强孤容发布了新的文献求助10
11秒前
11秒前
右耳77完成签到 ,获得积分10
12秒前
刘小谁完成签到,获得积分10
12秒前
TayBob完成签到,获得积分10
13秒前
渡花发布了新的文献求助10
13秒前
徐XU发布了新的文献求助10
14秒前
彭于晏的应助被个性的夜白采纳,获得10
15秒前
xiaoxiong完成签到,获得积分10
15秒前
MASAMI完成签到,获得积分10
15秒前
6rj发布了新的文献求助10
16秒前
16秒前
17秒前
酷酷的秦完成签到,获得积分10
18秒前
迅速水池完成签到,获得积分10
18秒前
睡不醒的喵完成签到,获得积分10
18秒前
情怀的应助被Han采纳,获得10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186734
求助须知:如何正确求助?哪些是违规求助? 9575007
关于积分的说明 21839114
捐赠科研通 7784289
什么是DOI,文献DOI怎么找? 3434808
关于科研通互助平台的介绍 2559206
邀请新用户注册赠送积分活动 2481611